News & Updates

Ivermectin falls flat against mild-to-moderate COVID-19

08 Mar 2025

Treatment with ivermectin for mild-to-moderate COVID-19 does not appear to reduce recovery time as compared with placebo, according to data from the ongoing ACTIV-6* study.

Ivermectin falls flat against mild-to-moderate COVID-19

08 Mar 2025

Digital CBT shows promise in pulmonary fibrosis-related anxiety

07 Mar 2025 by

Treatment with a digital cognitive behavioural therapy (CBT), dubbed Almee, demonstrates a clinically meaningful improvement in pulmonary fibrosis (PF)-related anxiety and is well-tolerated by patients, reports a study.

Digital CBT shows promise in pulmonary fibrosis-related anxiety

07 Mar 2025

Benralizumab offers durability in EGPA, adds value to patients switched from mepolizumab

07 Mar 2025 by

The attainment of remission in EGPA is durable whether treated with benralizumab for 2 years or switched to benralizumab after 52 weeks of mepolizumab treatment, with additional merits observed among those who switched, as indicated in the OLE of MANDARA

Benralizumab offers durability in EGPA, adds value to patients switched from mepolizumab

07 Mar 2025

Immune changes, persistent spike protein seen in people with PVS

06 Mar 2025 by

People with post-vaccination syndrome (PVS), a rare condition following receipt of COVID-19 jabs, exhibit distinct immunological patterns, including the reappearance of the dormant Epstein-Barr virus (EBV) and persistence of SARS-CoV-2 spike protein in the blood, according to new research.

Immune changes, persistent spike protein seen in people with PVS

06 Mar 2025

Postresuscitation care of OHCA patients lacks neuroprotection

03 Mar 2025 by

A considerable variability exists in postresuscitation care of patients with return of spontaneous circulation (ROSC) after out-of-hospital cardiac arrest (OHCA) at the emergency department (ED), which suggests gaps between recommended guidelines and clinical practice, according to a Singapore study.

Postresuscitation care of OHCA patients lacks neuroprotection

03 Mar 2025

Lifestyle factors may influence respiratory health

03 Mar 2025

Following a healthy diet rich in fruits, vegetables, and whole grains helps prevent the incidence of chronic obstructive pulmonary disorder (COPD), whereas poor sleep quality contributes to a risk increase, according to a study.

Lifestyle factors may influence respiratory health

03 Mar 2025

RE-BUILD app offers self-monitoring aid to ILD patients

28 Feb 2025

A novel smartphone application (app) has demonstrated its usability for self-monitoring and data collection in patients with interstitial lung disease (ILD), reports a study.

RE-BUILD app offers self-monitoring aid to ILD patients

28 Feb 2025

Lung function a potential biomarker for glaucoma

28 Feb 2025 by

Lung function measures are associated with risk of glaucoma, indicating their potential role as biomarkers for the optic neuropathy with a devastating visual impact, researchers from the Chinese University of Hong Kong, Princes of Wales Hospital and Hong Kong Eye Hospital have reported.

Lung function a potential biomarker for glaucoma

28 Feb 2025

Use of anti–IL-5 therapy in a patient with T2 inflammation–driven CRSwNP, HES, and asthma in a multidisciplinary clinic

26 Feb 2025 by

A 70-year-old female has a history of adult-onset asthma managed with a moderate-dose budesonide/formoterol inhaler. In 2019, she presented with skin rash and neuropathy (numbness). Complete blood counts showed elevated absolute eosinophil, peaking at 6,000 cells/μL. In conjunction with skin biopsy and nerve conduction studies, the diagnosis of hypereosinophilic syn¬drome (HES) was made.

Use of anti–IL-5 therapy in a patient with T2 inflammation–driven CRSwNP, HES, and asthma in a multidisciplinary clinic

26 Feb 2025

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

25 Feb 2025 by

Neither SARS-CoV-2 infection exposure nor COVID-19 vaccination during pregnancy poses a significant risk to early child development, as shown in a population-level study said to be the largest to date.

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

25 Feb 2025

News & Updates

Filter by Specialty:

Specialty:

Ivermectin falls flat against mild-to-moderate COVID-19

Ivermectin falls flat against mild-to-moderate COVID-19

Digital CBT shows promise in pulmonary fibrosis-related anxiety

Digital CBT shows promise in pulmonary fibrosis-related anxiety

Benralizumab offers durability in EGPA, adds value to patients switched from mepolizumab

Benralizumab offers durability in EGPA, adds value to patients switched from mepolizumab

Immune changes, persistent spike protein seen in people with PVS

Immune changes, persistent spike protein seen in people with PVS

Postresuscitation care of OHCA patients lacks neuroprotection

Postresuscitation care of OHCA patients lacks neuroprotection

Lifestyle factors may influence respiratory health

Lifestyle factors may influence respiratory health

RE-BUILD app offers self-monitoring aid to ILD patients

RE-BUILD app offers self-monitoring aid to ILD patients

Lung function a potential biomarker for glaucoma

Lung function a potential biomarker for glaucoma

Use of anti–IL-5 therapy in a patient with T2 inflammation–driven CRSwNP, HES, and asthma in a multidisciplinary clinic

Use of anti–IL-5 therapy in a patient with T2 inflammation–driven CRSwNP, HES, and asthma in a multidisciplinary clinic

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed

Prenatal COVID-19 infection, vaccination: Early child developmental concerns allayed